AIM
EW icon

Avanda Investment Management’s Edwards Lifesciences EW Stock Holding History

Avanda Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,444
Closed -$1.74M – 26
2025
Q4 		$1.74M Sell
20,444
-450
-2% -$36.9K 1.73% 14
2025
Q3 		$1.62M Hold
20,894
– – 1.28% 14
2025
Q2 		$1.63M Sell
20,894
-1,920
-8% -$143K 0.54% 21
2025
Q1 		$1.65M Buy
22,814
+447
+2% +$32K 0.59% 22
2024
Q4 		$1.66M Sell
22,367
-694
-3% -$48.6K 0.53% 21
2024
Q3 		$1.52M Sell
23,061
-24,201
-51% -$1.76M 0.3% 45
2024
Q2 		$4.37M Sell
47,262
-24,538
-34% -$2.17M 0.66% 41
2024
Q1 		$6.86M Buy
+71,800
New +$6.03M 0.92% 33

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Avanda Investment Management's EW Position: Q1 2026 in Review

Avanda Investment Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 20,444 shares — an estimated $1.74M sold.

Avanda Investment Management first reported a position in EW in Q1 2024 and held it in 8 quarters. The position peaked at $6.86M in Q1 2024. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Avanda Investment Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Avanda Investment Management sold 20,444 Edwards Lifesciences shares in Q1 2026, an estimated $1.74M.
  • Avanda Investment Management first reported a position in Edwards Lifesciences in Q1 2024 and held it in 8 quarters.
  • Avanda Investment Management's Edwards Lifesciences position peaked at $6.86M in Q1 2024.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Avanda Investment Management's 13F filing for Q1 2026, filed 5 May 2026.